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Identity 
Other names: MLN50, EVI149 
HGNC (Hugo): LASP1 
Location: 17q12-21 
Local order: from centromere to telomere are: TRAF4 
(alias MLN62/CART1), MLLT6 (alias AF17), LASP1, 




LASP1 encompasses 51.65 kb on the genomic level 
and consists of 7 exons. 
Transcription 
3845 bp mRNA, 783 bp coding sequence. 
Protein 
Description 
261 amino acids; 29 kDa. LASP1 encodes a member of 
a LIM (Lin-11, Isl-1 and Mec-3) protein subfamily and 
is characterized by a LIM motif (cysteine-rich 
LIM/double zinc finger motif) at the N-terminus, an 
SH3 domain (Src homology region 3) at the C-





Intracellular, cytoplasmic; associated with the F-actin 
rich cortical cytoskeleton. 
Function 
LASP1 plays an important role in the regulation of 
dynamic actin-based, cytoskeletal activities and cell
motility. Agonist-dependent changes in LASP1 
phosphorylation may also serve to regulate actin-
associated ion transport activities, not only in the 
parietal cell but also in certain other F-actin-rich 
secretory epithelial cell types. Together, (LIM-) 
nebulette, Lasp-1, and zyxin may play an important 
role in the organization of focal adhesions. 
Homology 
LASP family of proteins: actin-binding repeats similar 
to those in LASP1 are also present in other nebulin-
related proteins such as NEBL (nebulette, 107 kD 
actin-binding Z-disk protein) and NRAP (nebulin-
related anchoring protein); NRAP also contains an N-
terminal LIM domain and NEB (nebulin) a C-terminal 
SH3 domain, both of which are highly homologous to 
the respective domains of LASP1. 
Implicated in 
t(11;17)(q23;q12) --> MLL-LASP1 
Disease 
Infant AML-M4; only one case described so far. 
Abnormal protein 
The MLL-LASP1 chimeric protein consists of the AT-
hook DNA-binding domain and the methyltransferase 
motif including the CXXC zinc-finger domain of MLL 
and the SH3 domain of LASP1. 
Breast carcinomas 
Disease 
17q11-q21 amplification is found in about 25% of 
primary breast carcinomas; simultaneous amplification  
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and overexpression of LASP1 and ERBB2. 
Prognosis 
Poor clinical outcome; increase risk of relapse. 
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